TABLE 1.

Semiannual US compared to no surveillance for hepatocellular carcinoma

Model output	No surveillance	6‐month US
Interval cancer	N/A	10%
Size of main nodule
Mean (cm)	5.5	2.7
1–3 cm	8%	69%
3–5 cm	20%	24%
>5 cm	71%	7%
Curative treatment	11%	59%
Case fatality rate
Overall	77%	46%
1–3 cm	44%	37%
3–5 cm	68%	61%
>5 cm	83%	83%

Note: Baseline case scenario relies on a tumor doubling time of 90 days.

Abbreviations: N/A, not applicable; US, ultrasound.